Shares in Mylan have risen after the FDA gave a tentative ... giving it a shot at stealing market share from the $2 billion-plus brand, used to treat non-squamous non-small cell lung cancer ...

Mylan has paid $96.5 million to settle claims it delayed launching a generic of narcolepsy drug Provigil in exchange for a payment from the originator, Cephalon. Reuters reported the settlement ...

The pharmaceutical company Mylan has been in the hot seat with members ... half the list price of the branded drug. Manchin did also give off all the signs of a proud father, telling Bloomberg ...

If you have been diagnosed with moderate to severe chronic Shift Work Sleep Disorder (SWSD) and non-drug therapies have been unsuitable or unsuccessful, MODAFINIL MYLAN may be prescribed to keep ...

New Delhi, Dec 2 () Biotechnology major Biocon and drug firm Mylan NV on Monday announced the launch of biosimilar Ogivri, used for treatment of certain breast and gastric cancers, in the US market.